{"id":420133,"date":"2021-01-25T08:03:40","date_gmt":"2021-01-25T13:03:40","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=420133"},"modified":"2021-01-25T08:03:40","modified_gmt":"2021-01-25T13:03:40","slug":"orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\/","title":{"rendered":"OrthoSpin Ltd. Receives FDA Regulatory Clearance for its G2 System"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p \/>\n<p>YOKNEAM, <span class=\"xn-location\">Israel<\/span>, <span class=\"xn-chron\">Jan. 25, 2021<\/span> \/PRNewswire\/ &#8212; <a target=\"_blank\" href=\"http:\/\/trendlines.com\/portfolio\/orthospin\/\" rel=\"nofollow noopener noreferrer\">OrthoSpin Ltd. (&#8220;OrthoSpin&#8221;)<\/a>, announced today that it received regulatory clearance from the United States Food and Drug Administration (FDA) for its second generation, robotic, digitally enabled external fixation system for orthopedic treatments.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1425409\/OrthoSpin_Generation_2.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1425409\/OrthoSpin_Generation_2.jpg\" title=\"OrthoSpin\u2019s FDA-cleared Generation 2 robotic system enables automation of external fixation orthopedic treatments (credit: OrthoSpin).\" alt=\"OrthoSpin\u2019s FDA-cleared Generation 2 robotic system enables automation of external fixation orthopedic treatments (credit: OrthoSpin).\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>External fixation devices are a common treatment choice for bone lengthening, setting complex fractures, and correcting deformities. Patient compliance challenges and a lack of real-time feedback for physician follow-up present substantial challenges. Currently, effective treatment necessitates that patients manually adjust fixation devices daily, requiring complicated patient training. This may cause adjustment errors and non-compliance, potentially resulting in poor clinical outcomes.<\/p>\n<p>The Company has completed initial clinical cases in the U.S. and <span class=\"xn-location\">Israel<\/span> with the FDA-cleared OrthoSpin Generation 1 system which makes pre-programmed adjustments automatically without the need for patient involvement. Integrated software enables physicians to chart patient progress and, when required, immediately adjust treatment programs. The second-generation system represents a technological leap forward as it is more user friendly, covers all strut range sizes, and is lighter by 20%. <\/p>\n<p>&#8220;We are very excited to launch the Generation 2 OrthoSpin system,&#8221; said Dr <span class=\"xn-person\">Assaf Dekel<\/span>, Active Chairman of OrthoSpin. &#8220;We believe that robotic automation will revolutionize the hexapod bone deformity market and we are proud to play a part in this transformation.&#8221; <\/p>\n<p>Future applications, such as the ability to follow and modify treatment plans via smart phones and cloud-based AI algorithms treatment plans based on computerized historical data, have the potential to play an increasingly prominent role in medicine and healthcare. <\/p>\n<p>The OrthoSpin G2 system is approved in <span class=\"xn-location\">Israel<\/span> and-cleared for use in USA and can be used with the DePuy Synthes MAXFRAME\u2122 Multi-Axial Correction System. \u00a0<\/p>\n<p>\n        <b>About OrthoSpin<\/b>\n      <\/p>\n<p>OrthoSpin was founded in <span class=\"xn-chron\">December 2014<\/span> to offer a new robotic, digitally enabled external fixation system for orthopedic treatments. <a target=\"_blank\" href=\"http:\/\/trendlines.com\/portfolio\/orthospin\/\" rel=\"nofollow noopener noreferrer\">OrthoSpin Ltd.<\/a> is a portfolio company of <a target=\"_blank\" href=\"http:\/\/trendlines.com\/\" rel=\"nofollow noopener noreferrer\">\u00a0The Trendlines Group Ltd. (&#8220;Trendlines&#8221;) <\/a>\u00a0(SGX: 42T; OTCQX: TRNLY), traded on the Singapore Stock Exchange (SGX: 42T) and in <span class=\"xn-location\">the United States<\/span> as an American Depositary Receipt (ADR) on the OTCQX International (OTCQX: TRNLY). <\/p>\n<p>\u00a0<\/p>\n<p>\n        <b>For further information:\u00a0 <br \/><\/b><br \/>\n        <span class=\"xn-person\">Oren Cohen<\/span>, CEO OrthoSpin\u00a0\u00a0 <br \/><a target=\"_blank\" href=\"mailto:oren@orthospin.com\" rel=\"nofollow noopener noreferrer\">oren@orthospin.com<\/a>\u00a0 <br \/>Phone +972-54-334-2651\u00a0\u00a0\u00a0 <\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN57218&amp;sd=2021-01-25\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system-301213919.html\">http:\/\/www.prnewswire.com\/news-releases\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system-301213919.html<\/a><\/p>\n<p>SOURCE  OrthoSpin<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LN57218&amp;Transmission_Id=202101250800PR_NEWS_USPR_____LN57218&amp;DateId=20210125\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire YOKNEAM, Israel, Jan. 25, 2021 \/PRNewswire\/ &#8212; OrthoSpin Ltd. (&#8220;OrthoSpin&#8221;), announced today that it received regulatory clearance from the United States Food and Drug Administration (FDA) for its second generation, robotic, digitally enabled external fixation system for orthopedic treatments. External fixation devices are a common treatment choice for bone lengthening, setting complex fractures, and correcting deformities. Patient compliance challenges and a lack of real-time feedback for physician follow-up present substantial challenges. Currently, effective treatment necessitates that patients manually adjust fixation devices daily, requiring complicated patient training. This may cause adjustment errors and non-compliance, potentially resulting in poor clinical outcomes. The Company has completed initial clinical cases in the U.S. and Israel with the FDA-cleared OrthoSpin Generation 1 system &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;OrthoSpin Ltd. Receives FDA Regulatory Clearance for its G2 System&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-420133","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>OrthoSpin Ltd. Receives FDA Regulatory Clearance for its G2 System - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OrthoSpin Ltd. Receives FDA Regulatory Clearance for its G2 System - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire YOKNEAM, Israel, Jan. 25, 2021 \/PRNewswire\/ &#8212; OrthoSpin Ltd. (&#8220;OrthoSpin&#8221;), announced today that it received regulatory clearance from the United States Food and Drug Administration (FDA) for its second generation, robotic, digitally enabled external fixation system for orthopedic treatments. External fixation devices are a common treatment choice for bone lengthening, setting complex fractures, and correcting deformities. Patient compliance challenges and a lack of real-time feedback for physician follow-up present substantial challenges. Currently, effective treatment necessitates that patients manually adjust fixation devices daily, requiring complicated patient training. This may cause adjustment errors and non-compliance, potentially resulting in poor clinical outcomes. The Company has completed initial clinical cases in the U.S. and Israel with the FDA-cleared OrthoSpin Generation 1 system &hellip; Continue reading &quot;OrthoSpin Ltd. Receives FDA Regulatory Clearance for its G2 System&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-25T13:03:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1425409\/OrthoSpin_Generation_2.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"OrthoSpin Ltd. Receives FDA Regulatory Clearance for its G2 System\",\"datePublished\":\"2021-01-25T13:03:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\\\/\"},\"wordCount\":373,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1425409\\\/OrthoSpin_Generation_2.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\\\/\",\"name\":\"OrthoSpin Ltd. Receives FDA Regulatory Clearance for its G2 System - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1425409\\\/OrthoSpin_Generation_2.jpg\",\"datePublished\":\"2021-01-25T13:03:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1425409\\\/OrthoSpin_Generation_2.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1425409\\\/OrthoSpin_Generation_2.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OrthoSpin Ltd. Receives FDA Regulatory Clearance for its G2 System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OrthoSpin Ltd. Receives FDA Regulatory Clearance for its G2 System - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\/","og_locale":"en_US","og_type":"article","og_title":"OrthoSpin Ltd. Receives FDA Regulatory Clearance for its G2 System - Market Newsdesk","og_description":"PR Newswire YOKNEAM, Israel, Jan. 25, 2021 \/PRNewswire\/ &#8212; OrthoSpin Ltd. (&#8220;OrthoSpin&#8221;), announced today that it received regulatory clearance from the United States Food and Drug Administration (FDA) for its second generation, robotic, digitally enabled external fixation system for orthopedic treatments. External fixation devices are a common treatment choice for bone lengthening, setting complex fractures, and correcting deformities. Patient compliance challenges and a lack of real-time feedback for physician follow-up present substantial challenges. Currently, effective treatment necessitates that patients manually adjust fixation devices daily, requiring complicated patient training. This may cause adjustment errors and non-compliance, potentially resulting in poor clinical outcomes. The Company has completed initial clinical cases in the U.S. and Israel with the FDA-cleared OrthoSpin Generation 1 system &hellip; Continue reading \"OrthoSpin Ltd. Receives FDA Regulatory Clearance for its G2 System\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-25T13:03:40+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1425409\/OrthoSpin_Generation_2.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"OrthoSpin Ltd. Receives FDA Regulatory Clearance for its G2 System","datePublished":"2021-01-25T13:03:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\/"},"wordCount":373,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1425409\/OrthoSpin_Generation_2.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\/","name":"OrthoSpin Ltd. Receives FDA Regulatory Clearance for its G2 System - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1425409\/OrthoSpin_Generation_2.jpg","datePublished":"2021-01-25T13:03:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1425409\/OrthoSpin_Generation_2.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1425409\/OrthoSpin_Generation_2.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthospin-ltd-receives-fda-regulatory-clearance-for-its-g2-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"OrthoSpin Ltd. Receives FDA Regulatory Clearance for its G2 System"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/420133","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=420133"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/420133\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=420133"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=420133"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=420133"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}